Nuvation Bio Inc.

NYSE: NUVB · Real-Time Price · USD
2.75
-0.01 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
2.80
2.00%
After-hours: Aug 15, 2025, 07:39 PM EDT

Nuvation Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
14.36M 10.96M 7.87M 2.43M 1.7M 264K 264K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
10.4M 9.42M 7.32M 3.16M 1.65M 55K 55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
3.95M 1.54M 493K -793K -60K 58K 116K -199K -361K -437K -484K -421K -274K -201K -184K -141K -71K -30K
Operating Income
-224.64M -631.43M -592.63M -559.52M -537.75M -93.5M -99.82M -103.33M -106.33M -118.06M -119.73M -125.01M -118.46M -101.03M -93.32M -77.48M -66.23M -54.81M
Interest Income
22.89M 25.25M 27.06M 28.02M 27.82M 26.76M 24.61M 21.11M 16.71M 11.47M 7.45M 4.83M 3.55M 3.48M 2.96M 2.52M 2.12M 1.86M
Pretax Income
-202.9M -606.38M -567.94M -532.28M -510.72M -68.87M -75.8M -82.86M -90.41M -104.63M -104.2M -108.49M -103.26M -87.74M -86.85M -74.99M -64.05M -53.31M
Net Income
-202.9M -606.38M -567.94M -532.28M -510.72M -68.87M -75.8M -82.86M -90.41M -104.63M -104.2M -108.49M -103.26M -87.74M -86.85M -74.99M -64.05M -53.31M
Selling & General & Admin
119.6M 97.27M 69.17M 48.46M 36.66M 28.04M 28.48M 30.52M 30.78M 32.19M 31.92M 32.06M 29.69M 27.14M 24.28M 21.11M 18.36M 13.63M
Research & Development
108.99M 110.88M 99.12M 85.17M 76M 65.34M 71.29M 72.81M 75.54M 85.87M 87.82M 92.95M 88.78M 73.89M 69.04M 56.37M 47.88M 41.19M
Other Expenses
n/a -247K -247K -247K -475K -459K -459K -684K -719K -703K -872K -837K -744K -705K -644K -557K -439K -319K
Operating Expenses
228.37M 207.68M 167.83M 133.39M 112.42M 93.39M 99.77M 103.33M 106.33M 118.06M 119.73M 125.01M 118.46M 101.03M 93.32M 77.48M 66.23M 54.81M
Interest Expense
684K 395K 341K 252K 132K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
-198K 302K 244K 387K 387K -113K -55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
238.99M 217.32M 175.43M 136.61M 114.12M 93.5M 99.82M 103.33M 106.33M 118.06M 119.73M 125.01M 118.46M 101.03M 93.32M 77.48M 66.23M 54.81M
Income Tax Expense
n/a n/a 14.72K 14.72K 14.72K 14.72K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
340.75M 338.61M 336.93M 273.56M 244.74M 219.05M 218.99M 218.94M 218.85M 218.74M 218.5M 218.3M 216.6M 213.41M 210.36M 207.1M 204.02M 169.66M
Shares Outstanding (Diluted)
340.75M 338.61M 336.93M 273.56M 244.74M 219.05M 218.99M 218.94M 218.85M 218.74M 218.5M 218.3M 216.6M 213.41M 210.36M 207.1M 204.02M 169.66M
EPS (Basic)
-0.63 -2.35 -2.26 -2.17 -2.11 -0.31 -0.35 -0.38 -0.41 -0.48 -0.48 -0.5 -0.49 -0.42 -0.44 -0.39 -0.33 -0.27
EPS (Diluted)
-0.63 -2.35 -2.26 -2.17 -2.11 -0.31 -0.35 -0.38 -0.41 -0.48 -0.48 -0.49 -0.48 -0.41 -0.43 -0.39 -0.33 -0.27
EBITDA
-207.82M -611.35M -572.48M -544.12M -522.63M -81.11M -87.44M -90.95M -100.64M -117.86M -119.54M -124.82M -118.25M -100.83M -93.13M -77.31M -66.11M -54.71M
EBIT
-208.04M -611.81M -573M -544.48M -523.04M -81.32M -87.64M -91.14M -100.83M -118.06M -119.73M -125.01M -118.46M -101.03M -93.32M -77.48M -66.23M -54.81M
Depreciation & Amortization
691K 935K 683K 519K 412K 206K 204K 255K 417K 493K 484K 421K 274K 201K 184K 168K 124K 109K